Preoperative vaping prevalence and behavior of French surgical patients: A multicentre study

• Main Authors: Yann Gricourt, Hamadi Ghezal, Pierre G. Claret, Lana Zoric, Arnaud Chaumeron, Mathieu Raux, Bastian Nucci, Emmanuel Lorne, Jean Y. Lefrant, Philippe Cuvillon
• Format: Article
• Language: English
• Published: European Publishing 2019-11-01
• Series: Tobacco Induced Diseases
• Subjects: e-cigarette; vaping; tobacco; preoperative period
• Online Access: http://www.journalssystem.com/tid/Preoperative-Vaping-Prevalence-and-Behavior-of-French-Surgical-Patients-a-multicenter,114068,0,2.html

Introduction Prevalence and tobacco-related perioperative complications have been largely reported. The impact of vaping (e-cigarette use) on the perioperative period has been rarely evaluated. The purpose of this multicentre cross-sectional survey was to assess the prevalence of vaping and behaviour of patients undergoing elective surgery. Methods After institutional review board committee and patient approvals, patients (aged ≥18 years) scheduled for elective non-cardiac surgery in six French hospitals were assessed preoperatively. Demographic characteristics, and information on vaping, smoking or dual-use status and consumption were reported. Results In six centres, 1712 eligible patients were approached and 1664 patients were included in this study from June 2016 to January 2017. Of these, 62 patients used e-cigarettes in the preoperative period (3%; 95% CI: 2–4), including 24 exclusive e-cigarette users (1%; 95% CI: 1–2), 38 dual-users (2%; 95% CI: 2–3) and 365 smokers (22%; 95% CI: 20–24). Vapers were older than smokers (53 vs 47 years old; p=0.01). During the preoperative period, 12 patients (1%) reported vaping the morning of surgery. Conclusions In the preoperative period, vaping was ten-fold less prevalent than smoking. Although the clinical relevance may be weak, further research is needed to explore the real impact of vaping on patients’ outcomes and to elaborate on clinical recommendations. TRIAL REGISTRATION Clinical Trials.gov: NCT03594643